Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download


  Free Subscription


1 Antimicrob Agents Chemother
1 Clin Infect Dis
1 Emerg Infect Dis
1 Eur J Clin Microbiol Infect Dis
1 Eur Respir J
4 Int J Tuberc Lung Dis
2 J Clin Microbiol
3 PLoS One
1 Trop Med Int Health

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. IGNATIUS EH, Abdelwahab MT, Hendricks B, Gupte N, et al
    Pretomanid Pharmacokinetics in the Presence of Rifamycins: interim Results from a Randomized Trial among Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2020 Nov 23. pii: AAC.01196.
    PubMed         Abstract available

    Clin Infect Dis

  2. ASABOR EN, Vermund SH
    Confronting structural racism in the prevention and control of tuberculosis in the United States.
    Clin Infect Dis. 2020 Nov 26. pii: 6006871. doi: 10.1093/cid/ciaa1763.
    PubMed         Abstract available

    Emerg Infect Dis

  3. HALEY CA, Macias P, Jasuja S, Jones BA, et al
    Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

    Eur J Clin Microbiol Infect Dis

  4. ZHENG H, Zhong F, Yu G, Shen Y, et al
    Comparison of the diagnostic efficacy of the CapitalBio Mycobacterium real-time polymerase chain reaction detection test and Xpert MTB/RIF in smear-negative pulmonary tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2020 Nov 26. pii: 10.1007/s10096-020-04113.
    PubMed         Abstract available

    Eur Respir J

  5. MIRZAYEV F, Viney K, Linh NN, Gonzalez-Angulo L, et al
    World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
    Eur Respir J. 2020 Nov 26. pii: 13993003.03300-2020.
    PubMed         Abstract available

    Int J Tuberc Lung Dis

  6. ECHEVERRIA G, Espinoza W, de Waard JH
    How TB and COVID-19 compare: an opportunity to integrate both control programmes.
    Int J Tuberc Lung Dis. 2020;24:971-974.

  7. WILSON FA, Miller TL, Stimpson JP
    COVID-19 and TB control in immigrant communities.
    Int J Tuberc Lung Dis. 2020;24:975-977.

  8. VAN DER WALT M, Keddy KH
    How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease.
    Int J Tuberc Lung Dis. 2020;24:978-980.

    Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria.
    Int J Tuberc Lung Dis. 2020;24:981-982.

    J Clin Microbiol

  10. LORENTE-LEAL V, Liandris E, Pacciarini M, Botelho A, et al
    Direct PCR on tissue samples to detect Mycobacterium tuberculosis complex: an alternative to the bacteriological culture.
    J Clin Microbiol. 2020 Nov 25. pii: JCM.01404-20. doi: 10.1128/JCM.01404.
    PubMed         Abstract available

  11. HE Y, Lyon CJ, Nguyen DT, Liu C, et al
    Serum-based Diagnosis of Pediatric Tuberculosis by Assay of Mycobacterium tuberculosis Factors: a retrospective cohort study.
    J Clin Microbiol. 2020 Nov 25. pii: JCM.01756-20. doi: 10.1128/JCM.01756.
    PubMed         Abstract available

    PLoS One

  12. HORTER S, Achar J, Gray N, Parpieva N, et al
    Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    PLoS One. 2020;15:e0242359.
    PubMed         Abstract available

  13. BANU S, Haque F, Ahmed S, Sultana S, et al
    Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh.
    PLoS One. 2020;15:e0241437.
    PubMed         Abstract available

  14. AJUDUA FI, Mash RJ
    Implementing active surveillance for TB-The views of managers in a resource limited setting, South Africa.
    PLoS One. 2020;15:e0239430.
    PubMed         Abstract available

    Trop Med Int Health

  15. RAMLALL S, Lessells RJ, Naidu T, Sandra Mthembu S, et al
    Neurocognitive functioning in MDR-TB patients with and without HIV in KwaZulu-Natal, South Africa.
    Trop Med Int Health. 2020;25:919-927.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.